Mark Hazeltine is Chief Business Officer of EXAGEN INC.. Currently has a direct ownership of 190,205 shares of XGN, which is worth approximately $979,555. The most recent transaction as insider was on Mar 02, 2023, when has been sold 3,667 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 190K
0% 3M change
0% 12M change
Total Value Held $979,555

Mark Hazeltine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2023
SELL
Open market or private sale
-
3,667 Reduced 1.89%
190,205 Common Stock
Feb 27 2023
BUY
Grant, award, or other acquisition
-
100,000 Added 34.03%
193,872 Common Stock
Feb 08 2023
SELL
Open market or private sale
$15,658 $2.69 p/Share
5,821 Reduced 5.84%
93,872 Common Stock
Mar 01 2022
SELL
Payment of exercise price or tax liability
$23,076 $7.12 p/Share
3,241 Reduced 3.15%
99,693 Common Stock
Feb 04 2022
BUY
Grant, award, or other acquisition
-
63,500 Added 38.15%
102,934 Common Stock
May 17 2021
BUY
Exercise of conversion of derivative security
$503 $0.26 p/Share
1,934 Added 4.68%
39,434 Common Stock
MH

Mark Hazeltine

Chief Business Officer
Vista, CA

Track Institutional and Insider Activities on XGN

Follow EXAGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XGN shares.

Notify only if

Insider Trading

Get notified when an Exagen Inc. insider buys or sells XGN shares.

Notify only if

News

Receive news related to EXAGEN INC.

Track Activities on XGN